Cargando…

IF-03 Clinical Effectiveness of Oseltamivir or Zanamivir for Influenza A/H1N1 Virus with or without H274Y Mutation

Detalles Bibliográficos
Autores principales:	Kawai, Naoki, Ikematsu, Hideyuki, Iwaki, Norio, Kashiwagi, Seizaburo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society for Infectious Diseases. Published by Elsevier Ltd. 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129484/ http://dx.doi.org/10.1016/S1201-9712(09)60318-0

Ejemplares similares

Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010–2011 season: comparison with the previous season and with seasonal A(H3N2) and B
por: Kawai, Naoki, et al.
Publicado: (2012)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Treated with Nebulized Zanamivir
por: Da Dalt, Liviana, et al.
Publicado: (2010)

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir
por: Matsuzaki, Yoko, et al.
Publicado: (2010)

Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014
por: Trebbien, Ramona, et al.
Publicado: (2017)

Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)?
por: Yu, Kunqian, et al.
Publicado: (2009)

Oseltamivir/zanamivir: Lack of efficacy leading to fatal influenza A (H1N1) infection: case report
Publicado: (2013)

Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment
por: Tuna, Nazan, et al.
Publicado: (2012)

Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir
por: Meijer, Wouter J., et al.
Publicado: (2015)

Environmental Levels of the Antiviral Oseltamivir Induce Development of Resistance Mutation H274Y in Influenza A/H1N1 Virus in Mallards
por: Järhult, Josef D., et al.
Publicado: (2011)

I223R Mutation in Influenza A(H1N1)pdm09 Neuraminidase Confers Reduced Susceptibility to Oseltamivir and Zanamivir and Enhanced Resistance with H275Y
por: LeGoff, Jérome, et al.
Publicado: (2012)

Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant
por: Jia, Ruifang, et al.
Publicado: (2022)

Study of Oseltamivir and Zanamivir Resistance-Related Mutations in Influenza Viruses Isolated from Wild Mallards in Sweden
por: Orozovic, Goran, et al.
Publicado: (2014)

A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir
por: Abed, Yacine, et al.
Publicado: (2017)

Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds
por: Orozovic, Goran, et al.
Publicado: (2011)

PIV-33 Detection of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation during 2007–2008 influenza season from central and eastern part of Turkey
por: Carhan, A., et al.
Publicado: (2009)

Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
por: Duval, Xavier, et al.
Publicado: (2010)

Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial
por: Li, Min, et al.
Publicado: (2020)

Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza
por: Kashiwagi, Seizaburo, et al.
Publicado: (2016)

Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
por: Duval, Xavier, et al.
Publicado: (2010)

Dynamic residue interaction network analysis of the oseltamivir binding site of N1 neuraminidase and its H274Y mutation site conferring drug resistance in influenza A virus
por: Yadav, Mohini, et al.
Publicado: (2021)

Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K
por: Tran-To Su, Chinh, et al.
Publicado: (2013)

Reduced Sensitivity of Influenza A (H5N1) to Oseltamivir
por: McKimm-Breschkin, Jennifer L., et al.
Publicado: (2007)

Oseltamivir- and Amantadine-Resistant Influenza Virus A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2010)

Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2009)

Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
por: Reddy, David
Publicado: (2010)

The post‐infection outcomes of influenza and acute respiratory infection in patients above 50 years of age in Japan: an observational study
por: Ikematsu, Hideyuki, et al.
Publicado: (2011)

Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007–08
por: Hauge, Siri H, et al.
Publicado: (2009)

Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial
por: Kashiwagi, Seizaburo, et al.
Publicado: (2013)

Intravenous zanamivir for influenza myocarditis and enteral malabsorption
por: Jahns, Fritz-Patrick, et al.
Publicado: (2018)

Oseltamivir compounding in the hospital pharmacy during the (H1N1) influenza pandemic
por: de Mário Marin, Márcia Lúcia, et al.
Publicado: (2010)

Prone position ventilation, recruitment maneuver and intravenous zanamivir in severe refractory hypoxemia caused by influenza A (H1N1)
por: Biatto, Jair F P, et al.
Publicado: (2010)

Alloferon and Zanamivir Show Effective Antiviral Activity against Influenza A Virus (H1N1) Infection In Vitro and In Vivo
por: Lee, Dahae, et al.
Publicado: (2022)

Evaluation of immune response following one dose of an AS03(A)-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older
por: Ikematsu, Hideyuki, et al.
Publicado: (2012)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks
por: Anekthananon, T., et al.
Publicado: (2013)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks
por: Anekthananon, T., et al.
Publicado: (2013)

Intrahost emergent dynamics of oseltamivir-resistant virus of pandemic influenza A (H1N1) 2009 in a fatally immunocompromised patient
por: Hamada, Nobuyuki, et al.
Publicado: (2012)

Comparisons of oseltamivir‐resistant (H275Y) and concurrent oseltamivir‐susceptible seasonal influenza A(H1N1) virus infections in hospitalized adults, 2008–2009
por: Chan, Martin C. W., et al.
Publicado: (2012)

Evaluation of the Antiviral Response to Zanamivir Administered Intravenously for Treatment of Critically Ill Patients With Pandemic Influenza A (H1N1) Infection
por: Fraaij, P. L. A., et al.
Publicado: (2011)

Widespread Oseltamivir Resistance in Influenza A Viruses (H1N1), South Africa
por: Besselaar, Terry G., et al.
Publicado: (2008)

Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08
por: Hauge, Siri H., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nlev3a9c70hnmetnl1cv17h72v